On November 14, Dr. Cato Laurencin, the CEO of The Connecticut Convergence Institute for Translation in Regenerative Engineering, the Regenerative Engineering Society (RES), and the American Institute of Chemical Engineers celebrated 10 years of Regenerative Engineering.
Ten years prior to the day, Dr. Cato Laurencin published an historic piece in the Journal Science Translational Medicine with Dr. Yusuf Khan, announcing the new field of Regenerative Engineering. Regenerative Engineering involves the convergence of advanced materials sciences, stem cell science, physics, developmental biology, and clinical translation to address grand challenges such as regenerating complex tissues and organ systems.
Since the announcement of the field, texts on Regenerative Engineering have been published, a Journal Regenerative Engineering and Translational Medicine published by Springer Nature has been launched, and a new society, the Regenerative Engineering has begun.
“This is a field for everyone. Its principles are convergence, responsible science, democratization of science, and anti-racism, said Dr. Laurencin. I am particularly happy to see new centers involving Regenerative Engineering coming forth, including the Center for Advanced Regenerative Engineering (CARE) at Northwestern University and the newest center, the Center for Regenerative Engineering and Translational Ecosystem (CREATE), at Penn State University.”
Dr. Cato Laurencin and the Connecticut Convergence Institute for Translation in Regenerative Engineering team have published a number of articles on Regenerative Engineering. You can find the latest publications and journals on the website: https://health.uconn.edu/connecticut-convergence-institute/.